Related Experiment Video
Updated: Jun 12, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Atypical protein kinase C zeta exhibits a proapoptotic function in ovarian cancer
Irina Nazarenko1, Marcel Jenny, Jana Keil
1Karlsruhe Institute of Technology, Institute of Toxicology and Genetics, Hermann von Helmholtz Platz 1, Eggenstein-Leopoldshafen, Germany. irina.nazarenko@kit.edu
Abstract:
Intracellular signaling governed by serine/threonine kinases comprises the molecular interface between cell surface receptors and the nuclear transcriptional machinery. The protein kinase C (PKC) family members are involved in the control of many signaling processes directing cell proliferation, motility, and survival. Here, we examined a role of different PKC isoenzymes in protein phosphatase 2A (PP2A) and HRSL3 tumor suppressor-dependent cell death induction in the ovarian carcinoma cell line OVCAR-3. Phosphorylation and activity of PKC isoenzymes were measured in response to PP2A or phosphoinositide 3-kinase inhibition or HRSL3 overexpression. These experiments indicated a regulation of PKC, epsilon, zeta, and iota through PP2A and/or HRSL3, but not of PKCalpha and beta. Using isoform-specific peptide inhibitors and overexpression approaches, we verified a contribution to PP2A- and HRLS3-dependent apoptosis only for PKCzeta, suggesting a proapoptotic function of this kinase. We observed a significant proportion of human ovarian carcinomas expressing high levels of PKCzeta, which correlated with poor prognosis. Primary ovarian carcinoma cells isolated from patients also responded to okadaic acid treatment with increased phosphorylation of PKCzeta and apoptosis induction. Thus, our data indicate a contribution of PKCzeta in survival control in ovarian carcinoma cells and suggest that upregulation or activation of tyrosine kinase receptors in this tumor might impinge onto apoptosis control through the negative regulation of the atypical PKCzeta.
Insights
Protein Kinase C zeta (PKCzeta) promotes ovarian cancer cell survival. Its inhibition by PP2A or HRSL3 leads to apoptosis, suggesting PKCzeta as a therapeutic target for ovarian carcinoma.
Area of Science:
- Cellular signaling pathways
- Molecular mechanisms of cancer
Background:
- Protein Kinase C (PKC) family regulates cell proliferation, motility, and survival.
- Ovarian carcinoma is a significant health concern, necessitating research into its underlying molecular mechanisms.
Purpose of the Study:
- Investigate the role of specific PKC isoenzymes in apoptosis induction in ovarian carcinoma cells.
- Determine the relationship between PKC isoenzymes, protein phosphatase 2A (PP2A), and HRSL3 tumor suppressor in cell death pathways.
Main Methods:
- Measured phosphorylation and activity of PKC isoenzymes in OVCAR-3 cells under various conditions (PP2A/PI3K inhibition, HRSL3 overexpression).
- Utilized isoform-specific peptide inhibitors and overexpression techniques to assess PKCzeta's role in apoptosis.
- Analyzed PKCzeta expression levels in human ovarian carcinoma tissues and primary patient cells.
Main Results:
- PKC epsilon, zeta, and iota were regulated by PP2A and/or HRSL3, unlike PKCalpha and beta.
- PKCzeta was identified as a key mediator in PP2A- and HRSL3-dependent apoptosis, indicating a proapoptotic function.
- High PKCzeta expression in ovarian carcinomas correlated with poor prognosis, and patient cells showed increased PKCzeta phosphorylation and apoptosis upon okadaic acid treatment.
Conclusions:
- PKCzeta plays a crucial role in the survival of ovarian carcinoma cells.
- Targeting PKCzeta or understanding its regulation by upstream pathways may offer novel therapeutic strategies for ovarian cancer.
- Upregulation of tyrosine kinase receptors in ovarian tumors might impact apoptosis via negative regulation of PKCzeta.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Caspases
The Intrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway
The Extrinsic Apoptotic Pathway
